Details for New Drug Application (NDA): 215724
✉ Email this page to a colleague
The generic ingredient in ACYCLOVIR is acyclovir sodium. There are fifty-six drug master file entries for this compound. Nine suppliers are listed for this compound. Additional details are available on the acyclovir sodium profile page.
Pharmacology for NDA: 215724
Mechanism of Action | DNA Polymerase Inhibitors |
Medical Subject Heading (MeSH) Categories for 215724
Suppliers and Packaging for NDA: 215724
Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
---|---|---|---|---|---|---|---|---|
ACYCLOVIR | acyclovir | SUSPENSION;ORAL | 215724 | ANDA | Advagen Pharma Limited | 72888-079 | 72888-079-17 | 473 mL in 1 BOTTLE (72888-079-17) |
Profile for product number 001
Active Rx/OTC/Discontinued: | RX | Dosage: | SUSPENSION;ORAL | Strength | 200MG/5ML | ||||
Approval Date: | Aug 18, 2022 | TE: | AB | RLD: | No |
Complete Access Available with Subscription